関連する実験動画
Updated: Sep 9, 2025
08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
12.9K
不確定の可能性と冠動脈疾患における死亡率のクローナル血液形成
Moritz von Scheidt1,2, Shaunak S Adkar3, Johannes Krefting1,2
1Department of Cardiology, TUM Klinikum Deutsches Herzzentrum, Technical University Munich, Lazarettstr. 36, Munich D-80636, Germany.
European heart journal
|September 3, 2025
まとめ
不定の可能性のクローナル血液形成 (CHIP) は,冠動脈疾患 (CAD) の患者の死亡率を予測します. CHIPのTET2変異は,マクロファージの機能を変えてプラークの炎症と不安定性を促進し,エピジェネティック変化と有害な心血管疾患を関連付けます.
科学分野:
- 心血管医学
- 血液学
- 遺伝学
背景:
- 不定の可能性のクローン性血液形成 (CHIP) は心血管リスクと関連しているが,冠動脈疾患 (CAD) の役割は明確にする必要がある.
- CADにおけるCHIPの予後的意義とメカニズムの理解は,患者のアウトカムにとって極めて重要です.
研究 の 目的:
- 確認されたCAD患者の全因死亡率とCHIPとの関連を調査する.
- TET2変異を中心に,CHIPがCADに与える影響の細胞および分子メカニズムを探求する.
主な方法:
- 8612人のCAD患者の13のCHIPドライバ遺伝子の深層配列化.
- 3年間の死亡率の評価のために,CHIPキャリア (変異アレル頻度 ≥2%) と非キャリアの傾向スコアのマッチング.
- 死亡後のプラークプロテオミクス,RNAシーケンシング,およびin vitroマクロファージモデルを用いたメカニズム研究.
主要な成果:
- CHIPは,一致したCAD患者の3年死亡リスクの39%増加と関連していました (HR1. 39).
- 特定の変異 (TET2,ASXL1,DNMT3Aなど) 独立して死亡リスクが増加した.
- TET2 CHIP キャリアは,LDLR 調節によるマクロファージ脂質代謝と炎症経路の変化により,炎症と死核が増加した不安定なプラークを示した.
結論:
- CHIPは冠動脈疾患患者の死亡率の重要な予測因子として機能します.
- CHIPのTET2変異はプロアテロゲンマクロファージのフェノタイプを駆動し,脂質代謝と炎症の表遺伝的不調によってプラークの不安定性と心血管疾患の不良を増加させる.
関連する概念動画
01:26Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
01:21Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:19Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
01:21Myocarditis I: Introduction
28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
01:21Hematopoiesis
5.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.6K